MDC.AX - Medlab Clinical Limited
ASX - ASX Delayed price. Currency in AUD
As of 11:59AM AEST. Market open.
Stock chart is not supported by your current browser
| Previous close | 6.60 |
| Open | 6.60 |
| Bid | 0.00 x 3519200 |
| Ask | 0.00 x 165200 |
| Day's range | 6.60 - 6.60 |
| 52-week range | 6.45 - 14.94 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 15.071M |
| Beta (5Y monthly) | 1.10 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -547.50 |
| Earnings date | 28 Aug 2023 - 01 Sept 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 18.84 |
GlobeNewswireMEDLAB ANNOUNCES FAVOURABLE INTERIM READOUT OF NANABIS™ REAL-WORLD EVIDENCE (RWE) MEDCARE STUDY
N=1,172 Australian pain patientsDatapoints collected from commencing NanaBis™ (baseline) up to month 1255% improvement in pain relief75% of patients reduced their opioid use31% Improvements in Quality of Life as it relates to pain interference92% of patients with bone metastasis from cancer had reduced their pain severity and pain interference (Quality of Life) scores at 6-monthsNew “ENHANCE” study expects to onboard March 2023 Sydney, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Medlab Clinical Ltd (ASX:M
Simply Wall St.Medlab Clinical Full Year 2022 Earnings: Beats Expectations
Medlab Clinical ( ASX:MDC ) Full Year 2022 Results Key Financial Results Revenue: AU$1.54m (up 110% from FY 2021). Net...
- Simply Wall St.
What You Need To Know About Medlab Clinical Limited's (ASX:MDC) Investor Composition
Every investor in Medlab Clinical Limited ( ASX:MDC ) should be aware of the most powerful shareholder groups. Large...